|
| |
| | 67630 | | 26.06.2021 | | Mepha Pharma AG | | | | | | 25.06.2026 | | | | | | 01.07.10. | | | | 01.07.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Lacosamid-Mepha 50 mg | Filmtabletten | Coated tablets (Lacosamidum 50 mg) | N03AX18 | CI | 02 | Lacosamid-Mepha 100 mg | Filmtabletten | Coated tablets (Lacosamidum 100 mg) | N03AX18 | | 03 | Lacosamid-Mepha 150 mg | Filmtabletten | Coated tablets (Lacosamidum 150 mg) | N03AX18 | | 04 | Lacosamid-Mepha 200 mg | Filmtabletten | Coated tablets (Lacosamidum 200 mg) | N03AX18 | |
|
|
|